GRI Bio GRI
NASDAQ GRI
$1.67 -0.06 (-3.47%)
At close: Aug 20, 2026 · 4:00 PM EDT

GRI Bio (GRI) Current Leases (2020 - 2026)

GRI Bio (GRI) posted quarterly Current Leases of $58000.0 for Q1 2026, up 16.0% year-over-year from $50000.0 in Q1 2025, and up 3.57% quarter-over-quarter from $56000.0 in Q4 2025.

GRI Bio (GRI) Current Leases (2020 - 2026) Analysis & Trends

GRI Bio's Current Leases history runs 7 years deep, the most recent figure standing at $58000.0 for Q1 2026.

  • In Q1 2026, Current Leases rose 16.0% year-over-year to $58000.0; the TTM figure through Mar 2026 stood at $58000.0 (up 16.0% YoY), while the FY2025 annual figure was $56000.0, up 16.67% from the prior year.
  • Current Leases for Q1 2026 stood at $58000.0, up from $56000.0 in the prior quarter.
  • The five-year high for Current Leases was $58000.0 in Q1 2026, with the low at $14000.0 in Q4 2023.
  • The 5-year median for Current Leases is $48000.0 (2024), against an average of $45615.4.
  • The sharpest annual moves came in 2023 and 2024: Current Leases plunged 75.44% in 2023, then soared 242.86% in 2024.
  • GRI Bio's Current Leases stood at $57000.0 in 2022, then slumped by 75.44% to $14000.0 in 2023, then jumped by 242.86% to $48000.0 in 2024, then rose by 16.67% to $56000.0 in 2025, then grew by 3.57% to $58000.0 in 2026.
  • Business Quant data shows GRI's Current Leases at $58000.0 in Q1 2026, $56000.0 in Q4 2025, and $54000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 21.95 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 45.93 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 6.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -
10 GRI Bio 3.07 Mn 3.07 Mn - 44,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 58,000.00
Dec 31, 2025 56,000.00
Sep 30, 2025 54,000.00
Jun 30, 2025 52,000.00
Mar 31, 2025 50,000.00
Dec 31, 2024 48,000.00
Sep 30, 2024 47,000.00
Jun 30, 2024 45,000.00
Mar 31, 2024 43,000.00
Dec 31, 2023 14,000.00
Sep 30, 2023 28,000.00
Jun 30, 2023 41,000.00
Dec 31, 2022 57,000.00
Mar 31, 2021 95,000.00
Dec 31, 2020 105,000.00